Lithium treatment reduces suicide risk in recurrent major depressive disorder.

@article{Guzzetta2007LithiumTR,
  title={Lithium treatment reduces suicide risk in recurrent major depressive disorder.},
  author={Francesca Guzzetta and L. Tondo and F. Centorrino and R. Baldessarini},
  journal={The Journal of clinical psychiatry},
  year={2007},
  volume={68 3},
  pages={
          380-3
        }
}
  • Francesca Guzzetta, L. Tondo, +1 author R. Baldessarini
  • Published 2007
  • Psychology, Medicine
  • The Journal of clinical psychiatry
  • OBJECTIVE Evidence that clinical treatment reduces suicide risk in major depressive disorder (MDD) is limited and inconsistent. Since lithium shows major antisuicidal effects in bipolar disorders and in heterogeneous mood disorder samples, we evaluated evidence of antisuicidal effects of lithium in patients with recurrent MDD. DATA SOURCES We searched MEDLINE (January 1966 to April 2006; search terms: lithium, suicide, affective disorder, depression, major depression, and mood disorder) for… CONTINUE READING

    Figures, Tables, and Topics from this paper.

    Pharmacological prevention of suicide in patients with major mood disorders
    31
    Depression , suicide , and violence Suicide and depression
    1
    Suicide Prevention with Lithium
    The Effect of Pharmacotherapy on Suicide Rates in Bipolar Patients
    13
    Lithium treatment for unipolar major depressive disorder: Systematic review
    8

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 41 REFERENCES
    Lithium treatment and risk of suicidal behavior in bipolar disorder patients.
    150
    Suicide mortality in patients on lithium maintenance therapy.
    33
    Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).
    1004
    Suicidality in pediatric patients treated with antidepressant drugs.
    865
    Suicide in 406 Mood-Disorder Patients With and Without Long-Term Medication: A 40 to 44 Years' Follow-Up
    253